Accumulating evidence indicates that tumor immune microenvironment (particularly regarding PD-1, PD-L1/2, forkhead box P3 (Foxp3), CD80, and CD86 expression) and immune checkpoint signaling play decisive roles in tumor immune evasion and growth 10. This evidence concerns the gene PDCD1 and neoplasm.